A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab-Reference-Cited by-同舟云学术

A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab

Published:2021-07-19 Issue:1 Volume:88 Page:290-302
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Chang Hsuan Ping¹,Shakhnovich Valentina²³,Frymoyer Adam⁴,Funk Ryan Sol⁵,Becker Mara L.⁶⁷,Park K. T.⁸,Shah Dhaval K.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences The State University of New York at Buffalo Buffalo NY United States

2. Children's Mercy Kansas City Kansas City MO United States

3. University of Missouri‐Kansas City School of Medicine Kansas City MO United States

4. Department of Pediatrics Stanford University School of Medicine Stanford CA United States

5. Department of Pharmacy Practice University of Kansas School of Pharmacy Kansas City KS United States

6. Department of Pediatrics, Division of Rheumatology Duke University Durham NC United States

7. Duke Clinical Research Institute Durham NC United States

8. Genentech, Inc. South San Francisco CA USA

Funder

Center for Strategic Scientific Initiatives, National Cancer Institute

National Institute of Allergy and Infectious Diseases

National Institute of Child Health and Human Development

National Institute of Diabetes and Digestive and Kidney Diseases